a b s t r a c t
TNFa, a significant immune mediator, may contribute to the initiation and progression of the ischemic stroke. Genetics of TNFa molecule may have an important role in the risk of ischemic stroke. The most interesting aspects of the G-308A polymorphism remain unexplained; there are many discrepancies between the results. Differences in the ethnicity of the studied cohorts may be taken as one of the possibility. Our study material consisted of 101 patients with ischemic stroke, including 30% classified as lacunar stroke. The diagnosis was based on the presence of rapidly developing neurological signs lasting longer then 24 h and confirmed by neuroimaging matter. All patients were of Polish Caucasian origin. Randomly selected 100 individuals without any sign of the vascular disease of central nervous system were taken as the control material. The frequency of polymorphism G-308A in TNFa gene was determined as described by Rubattu et al. [11] . The genotype distribution in our material was similar and statistically insignificant between patients and controls. The heterozygotic G/A genotype was detected in 9% of patients and in 15% of control materials, homozygotic A/A was found in 5% of patients and only in one of control and G/G in 87% of patients and in 84% of control individuals.
Our results are negative with respect to the impact of 308 TNFa polymorphism on the risk of 1.
Introduction
The ischemic stroke is one of the most frequent causes of mortality and morbidity in the general population. There are now increasing number of evidences that proinflammatory cytokines contribute to the pathomechanism of stroke. The tumor necrosis factor a (TNFa) seems to be one of the most important cytokines. There are many studies concerning the genetics of TNFa in connection with cerebro-vascular diseases in various world regions. However, there are still several controversies related to that subject.
Um et al. [1] reported that the TNFa GG genotype in Koreans happened to increase the relative risk for cerebral infarction and concluded that the TNF-alpha 308 locus plays an important role in the pathogenesis of cerebral infarction. Lee et al. [2] presented evidence that TNF-alpha gene polymorphism is associated with the increased susceptibility to ischemic stroke in Korean population. Trifunovic Cvetkovic et al. [3] claimed that in Swedish patients the A1A1 genotype of TNFa is associated with risk of stroke. According to Lalouschek et al. [4] carriers of the TNF-alpha (308) A allele face an increased risk of stroke only in association with a febrile episode.
Harcom et al. [5] presented evidence demonstrating that patients with ischemic stroke in Hungarian population had a significantly lower frequency of the 308A allele compared to healthy subjects. Of great interest are the conclusions of Tong et al. [6] that TNF-alpha 308 GA heterozygotes in the Chinese and Uyghur population may be protected against ischemic stroke. Results presented by Kim et al. [7] suggested that TNF-a 308 G!A and 238 G!A polymorphisms are responsible for susceptibility to ischemic stroke in Korean population.
Pereira et al. [8] basing on their metaanalyses concluded that the G-308A polymorphism is unlikely to be associated with an increased risk of ischemic stroke in Caucasians whereas in Asians such polymorphism might represent a protective factor. Recent publications of metaanalyses by Cui et al. [9] express an opinion that despite some controversies it may be assumed that TNF-a is involved in the pathogenesis of stroke.
The significant differences between the European and Asian populations concerning the impact of the TNF-a gene in the pathogenesis of stroke certify that further respective studies in Caucasians are necessary.
Material and methods
The study material consisted of 101 patients (69 males and 32 females), aged 48-85 years, with ischemic stroke. The diagnosis was based on the presence of rapidly developing neurological signs lasting longer than 24 h. Using the TOAST criteria proposed by Goldstein et al. [10] the studied patients have been classified to the following subgroups: 30 cases -lacunar stroke, 18 patients -cardioembolic, 16 cases -atherosclerotic group and 16 as undetermined etiologycryptogenic. The diagnosis was confirmed by neuroimaging methods (CT scan or/and MRI). All individuals were of Polish Caucasian origin. Patients with hemorrhagic stroke were excluded. Randomly selected 100 unrelated individuals without any signs of the vascular disease of central nervous system, matched for gender and age, were taken as control material. The control material consisted of 60 males and 40 females, aged 46-78 years with diagnose of lumbar pain (65 cases) and neurotic symptoms (35 patients). Both subgroups were without any inflammatory symptoms. Methods: The frequency of polymorphism G-308A in tumor necrosis factor-alpha (TNF-a) gene was determined as described by Rubattu et al. [11] . The genomic DNA was extracted from a whole blood, collected on EDTA, using the isolation kit of A&A Biotechnology. In the next step, PCR was used to amplify a 519 bp fragment of the TNF promoter region using selected primers: 5 0 -CAAACACAGGCCTCAGGACTC-3 0 and 5 0 -
Then, 519 bp product was submitted to NESTED PCR using specific primers designed with the last nucleotide 
complementary to the allelic variant, according to G and T at the end of primer. The allelic type was determined by electrophoresis in 1.5% agarose gel, according to the presence of specific length NESTED PCR products.
Results
The genotype and allelic distributions were compared between controls and patients with stroke. In the control group the heterozygotic G/A genotype of TNF was detected in 15% of individuals. Homozygotic A/A was found in only one control and the G/G in 84% control individuals. Allelic distribution in the control group accorded to 9% A and 91% G individuals. The genotype distribution in patients was similar and statistically insignificant. The heterozygotic G/A genotype was detected in 9 individuals (9%), homozygotic A/A was found in 5 individuals (5%) and G/G in 87 individuals (87%), with allelic distribution of A = 9% and G = 91% (Table 1) .
Discussion
A significant role of an inflammatory mechanism in stroke is evident. Clinical implications of brain-immune interactions and ischemic stroke were presented in a recent comprehensive review paper of Kamel and Iadecola [12] . The authors indicate that the immune activation may cause secondary tissue injury, but it is not clear whether modulating the acute immune response can produce clinical benefits in the treatment of stroke patients. The inflammatory reaction can be influenced by functional polymorphism in compounds of the immune system. An increased expression of proinflammatory cytokines, including tumor necrosis factor (TNFa) has been found in the plasma and cerebro-spinal fluid of patients with acute ischemic stroke. TNFa, a significant immune mediator, may contribute to the initiation and progression of the ischemic stroke. Tuttolomondo et al. [13] showed significantly higher TNFa plasma levels in stroke patients of cardioembolic subtype, whereas in lacunar subtype TNFa plasma level was significantly lower. In our material the lacunar stroke subtype was as high as 30% and cardioembolic subtype as 18%. Therefore it seems clear that the group of ischemic stroke patients taken as a whole compared with the control material showed no differences in the genotype and allelic distribution. Genetics of TNFa molecule, or variability in its gene, may have an important role in the risk of ischemic stroke. The most studied and interesting aspects of the G-308A polymorphism remain unexplained: there are many discrepancies between the results. However, the cause of this is not clear. Differences in the ethnicity of the studied cohorts may be taken as one of the possibilities. In Caucasians living in European countries, such as Hungary and Austria, as well as in pediatric stroke patients in Turkey (Karahan et al. [14] ), TNFa 308 G/A polymorphism did not associate with the risk of ischemic stroke. Our results obtained in the cohort of Caucasians patients living in Poland are also negative with respect to the impact of G-308A TNFa polymorphism on the risk of ischemic stroke. In contrast are the findings of Rubattu et al. [11] , who established a role of TNFa gene variants on juvenile ischemic stroke in Italy. Also Trifunovic Cvetkovic et al. [3] indicated an association between allele A1 of the TNFa polymorphism and stroke in hypertensive male Swedish cases. The interesting point raised by Gupta et al. [15] should be added that G-308A polymorphism of the TNFa gene may be associated with hypertension and hypercholesterolemia. This indirectly leads to ischemic stroke. Such a relationship must be taken into account.
The conclusion has to be issued that further studies are required in various groups of patients in different countries and other parts of Poland, as long as this very serious problem is not validly resolved. However it seems that studies of 101 patients living in one region of Poland are conclusive for that geographical region.
Conclusion
G-308A TNFa polymorphism is not related to the risk of ischemic stroke in Caucasians living in western Poland.
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